Harnessing mixed chimerism and programmed cell death protein 1/programmed death ligand 1 signaling for transplant tolerance

被引：0
|
作者：
Li, Shuang [2 ]
Zou, Dawei [1 ,3 ]
机构：
[1] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA
[2] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Dept Surg, Houston, TX USA
[3] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol Transplant Sci Ctr, 6670 Bertner Ave,R7-430-3, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2024年 / 24卷 / 01期
关键词：
T cell; transplant tolerance; mixed chimerism; PD-1/PD-L1; T cell exhaustion; T cell anergy;
D O I：
10.1016/j.ajt.2023.09.016
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
    Lee, Joo Sang
    Ruppin, Eytan
    JAMA ONCOLOGY, 2019, 5 (11) : 1614 - 1618
  • [22] Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer Reply
    Wang, Zhijie
    Zhao, Zhengyi
    Wang, Jie
    JAMA ONCOLOGY, 2020, 6 (07) : 1116 - +
  • [23] Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
    Jaafar, Jaafar
    Fernandez, Eugenio
    Alwan, Heba
    Philippe, Jacques
    ENDOCRINE CONNECTIONS, 2018, 7 (05): : R196 - R211
  • [24] Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoids
    Sun, Lejia
    Yang, Huayu
    Mao, Yilei
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [25] Association of disease activity with programmed cell death 1 and its ligand programmed cell death ligand 1 expressions in lupus patients
    Eissa, Eman
    Kandil, Rania
    El-Ghobashy, Nehal
    Abdelfattah, Walaa
    Hammouda, Zainab
    Gadelsayed, Sara Medhat
    Bayoumi, Faten
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (04) : 347 - 352
  • [26] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    慢性疾病与转化医学（英文）, 2019, 5 (03) : 170 - 177
  • [27] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu Qiang
    Li Chun-Sheng
    中华医学杂志英文版, 2017, 130 (08) : 986 - 992
  • [28] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu, Qiang
    Li, Chun-Sheng
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 986 - 992
  • [29] Disrupting the Interplay between Programmed Cell Death Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids in Treating Cancer
    Chou, Liyushang
    Callmann, Cassandra E.
    Dominguez, Donye
    Zhang, Bin
    Mirkin, Chad A.
    ACS CENTRAL SCIENCE, 2022, 8 (09) : 1299 - 1305
  • [30] PROGRAMMED CELL DEATH-1 INTERACTION WITH PROGRAMMED CELL DEATH LIGAND REGULATES NEURONAL CELL DEATH IN THE MOUSE RETINA
    Gandhi, N. M.
    Sham, C.
    Chen, L.
    Yang, X.
    Sharpe, A. H.
    Freeman, G.
    Braun, J.
    Gordon, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 237 - 237
12345